1547 related articles for article (PubMed ID: 19022801)
21. Stabilization and humanization of a single-chain Fv antibody fragment specific for human lymphocyte antigen CD19 by designed point mutations and CDR-grafting onto a human framework.
Kügler M; Stein C; Schwenkert M; Saul D; Vockentanz L; Huber T; Wetzel SK; Scholz O; Plückthun A; Honegger A; Fey GH
Protein Eng Des Sel; 2009 Mar; 22(3):135-47. PubMed ID: 19188138
[TBL] [Abstract][Full Text] [Related]
22. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
[TBL] [Abstract][Full Text] [Related]
23. Construction and humanization of a functional bispecific EGFR × CD16 diabody using a refolding system.
Asano R; Nakayama M; Kawaguchi H; Kubota T; Nakanishi T; Umetsu M; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I
FEBS J; 2012 Jan; 279(2):223-33. PubMed ID: 22074399
[TBL] [Abstract][Full Text] [Related]
24. Construction and characterization of a humanized anti-gamma-Ig receptor type I (Fc gamma RI) monoclonal antibody.
Graziano RF; Tempest PR; White P; Keler T; Deo Y; Ghebremariam H; Coleman K; Pfefferkorn LC; Fanger MW; Guyre PM
J Immunol; 1995 Nov; 155(10):4996-5002. PubMed ID: 7594506
[TBL] [Abstract][Full Text] [Related]
25. Humanization of an anti-human IL-6 mouse monoclonal antibody glycosylated in its heavy chain variable region.
Sato K; Ohtomo T; Hirata Y; Saito H; Matsuura T; Akimoto T; Akamatsu K; Koishihara Y; Ohsugi Y; Tsuchiya M
Hum Antibodies Hybridomas; 1996; 7(4):175-83. PubMed ID: 9140729
[TBL] [Abstract][Full Text] [Related]
26. Human anti-CD30 recombinant antibodies by guided phage antibody selection using cell panning.
Klimka A; Matthey B; Roovers RC; Barth S; Arends JW; Engert A; Hoogenboom HR
Br J Cancer; 2000 Jul; 83(2):252-60. PubMed ID: 10901379
[TBL] [Abstract][Full Text] [Related]
27. Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor.
Figini M; Martin F; Ferri R; Luison E; Ripamonti E; Zacchetti A; Mortarino M; Di Cioccio V; Maurizi G; Allegretti M; Canevari S
Cancer Immunol Immunother; 2009 Apr; 58(4):531-46. PubMed ID: 18704410
[TBL] [Abstract][Full Text] [Related]
28. Potential of primate monoclonal antibodies to substitute for human antibodies: nucleotide sequence of chimpanzee Fab fragments.
Ehrlich PH; Moustafa ZA; Harfeldt KE; Isaacson C; Ostberg L
Hum Antibodies Hybridomas; 1990; 1(1):23-6. PubMed ID: 2129418
[TBL] [Abstract][Full Text] [Related]
29. Kinetic analysis of the interactions of recombinant human VpreB and Ig V domains.
Hirabayashi Y; Lecerf JM; Dong Z; Stollar BD
J Immunol; 1995 Aug; 155(3):1218-28. PubMed ID: 7636190
[TBL] [Abstract][Full Text] [Related]
30. Fusion of a recombinant antibody fragment with a homo-amino-acid polymer: effects on biophysical properties and prolonged plasma half-life.
Schlapschy M; Theobald I; Mack H; Schottelius M; Wester HJ; Skerra A
Protein Eng Des Sel; 2007 Jun; 20(6):273-84. PubMed ID: 17595342
[TBL] [Abstract][Full Text] [Related]
31. Cloning and expression in E. coli of a functional Fab fragment obtained from single human lymphocyte against anthrax toxin.
Masri SA; Rast H; Hu WG; Nagata LP; Chau D; Jager S; Mah D
Mol Immunol; 2007 Mar; 44(8):2101-6. PubMed ID: 17045651
[TBL] [Abstract][Full Text] [Related]
32. Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab')2 fragment of anti-CD16 antibody.
Jewett A; Teruel A; Romero M; Head C; Cacalano N
Cancer Immunol Immunother; 2008 Jul; 57(7):1053-66. PubMed ID: 18188563
[TBL] [Abstract][Full Text] [Related]
33. An expanded genetic code facilitates antibody chemical conjugation involving the lambda light chain.
Kato A; Ohtake K; Tanaka Y; Yokoyama S; Sakamoto K; Shiraishi Y
Biochem Biophys Res Commun; 2021 Mar; 546():35-39. PubMed ID: 33561746
[TBL] [Abstract][Full Text] [Related]
34. Determination of the relative affinities of antibody fragments expressed in Escherichia coli by enzyme-linked immunosorbent assay.
Watkins JD; Beuerlein G; Pecht G; McFadden PR; Glaser SM; Huse WD
Anal Biochem; 1997 Nov; 253(1):37-45. PubMed ID: 9356139
[TBL] [Abstract][Full Text] [Related]
35. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
[TBL] [Abstract][Full Text] [Related]
36. Recognition of defined epitopes by affinity-purified anti-immunoglobulin fab autoantibodies isolated from HIV-infected humans.
Marchalonis JJ; Garza A; Lake DF; Landsperger WJ; Süsal C
J Mol Recognit; 1999; 12(3):169-76. PubMed ID: 10398407
[TBL] [Abstract][Full Text] [Related]
37. Bacterial expression of neutralizing mouse monoclonal antibody Fab fragments to Hantaan virus.
Liang M; Chu YK; Schmaljohn C
Virology; 1996 Mar; 217(1):262-71. PubMed ID: 8599211
[TBL] [Abstract][Full Text] [Related]
38. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
[TBL] [Abstract][Full Text] [Related]
39. [Expression of antibody Fab against platelet IIb/IIIa in E.coli and characterization of its biological activity].
Yang YC; Lai CN; Wang Y; Shen BF; Li Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep; 20(5):563-7. PubMed ID: 15367348
[TBL] [Abstract][Full Text] [Related]
40. In vivo biotinylated recombinant antibodies: construction, characterization, and application of a bifunctional Fab-BCCP fusion protein produced in Escherichia coli.
Weiss E; Chatellier J; Orfanoudakis G
Protein Expr Purif; 1994 Oct; 5(5):509-17. PubMed ID: 7827508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
